Vesalius Biocapital offers venture capital
to young European innovative life science companies
FF Pharmaceuticals focuses on the development of novel disease-modifying therapeutics for the treatment of inflammatory diseases
Antibody therapeutics
The Netherlands / Belgium
Investing Phase